Ovid Therapeutics Inc. (OVID) Operating margin 2020–2025
Ovid Therapeutics Inc. (OVID) operating margin by fiscal year — reported operating income divided by reported revenue.
-585.2%FY2025 · since FY2020: -645.4% → -585.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -585.2% | +10348.5 pp |
| FY2024 | -10933.7% | +4189.0 pp |
| FY2023 | -15122.7% | -11426.3 pp |
| FY2022 | -3696.4% | -3756.0 pp |
| FY2021 | 59.6% | +705.0 pp |
| FY2020 | -645.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice